Pharmaceuticals

Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report

  • MAR2160198
  • 27 Pages
  • September 2017
  • Pharmaceuticals
Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report

Summary

Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Grupo Ferrer Internacional SA (Ferrer) is a pharmaceutical company based in Spain. The company manufactures and markets pharmaceutical products for various therapeutic areas such as cardiovascular, central nervous system, oncology, dermatology, gastrointestinal, musculoskeletal system, pain management, pediatrics and the respiratory system. It also offers diagnostics services through its subsidiary Ferrer inCode. Apart from these, Ferrer offers vaccine solutions for allergies, generic drugs and consumer healthcare products such as dermocosmetics, sunscreens, food supplements, infant nutrition products, over-the counter medicines, insect repellants and antilice products. The company also offers fine chemicals, and food and feed ingredients. It operates production facilities across Germany, Mexico and Spain. The company also operates a logistics center in Spain. Ferrer is headquartered in Barcelona, Spain.

Scope

- Detailed information on Grupo Ferrer Internacional SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Grupo Ferrer Internacional SA in the form of a SWOT analysis
- An in-depth view of the business model of Grupo Ferrer Internacional SA including a breakdown and examination of key business segments
- Intelligence on Grupo Ferrer Internacional SA's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Grupo Ferrer Internacional SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Grupo Ferrer Internacional SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Grupo Ferrer Internacional SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Grupo Ferrer Internacional SA's business structure, strategy and prospects.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

April 2018| $5370 | Pre Book Price:$4699

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

April 2018| $4995 | Pre Book Price:$4371

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

April 2018| $5370 | Pre Book Price:$4699

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

April 2018| $2850 | Pre Book Price:$2494

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

April 2018| $2850 | Pre Book Price:$2494

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

April 2018| $2850 | Pre Book Price:$2494

2019 © Copyright Big Market Research

View Pricing >>